American researchers studying nearly 5,000 men have found that deep visceral fat surrounding internal organs reduces testosterone levels far more than chronological aging.
The study, published in the Journal of the Endocrine Society, revealed that the accumulation of hidden abdominal fat around vital organs is a major driver of hormone decline in adult men.
While testosterone typically begins a gradual, progressive decline starting at age 35, the new findings indicate that age itself becomes far less significant once body fat distribution is taken into account.
Visceral fat is an internal adipose tissue located deep within the abdominal cavity, where it wraps around key organs including the liver, stomach, and intestines. It differs fundamentally from subcutaneous fat, which rests directly beneath the skin and can be pinched.
Testosterone serves as the primary male sex hormone, playing a crucial role in maintaining muscle mass, bone density, red blood cell production, and overall reproductive health. Medical experts have long recognized that visceral fat is metabolically active, releasing inflammatory chemicals into the bloodstream that can disrupt metabolic function.
Fat distribution outweighs age in hormone decline
To evaluate how body composition influences hormone levels, researchers analyzed health data from almost 5,000 American men aged 20 to 59. When comparing different physical and physiological metrics, they discovered a strong association between high levels of visceral fat and lower total testosterone concentrations.
Across the entire age range examined, the relationship between visceral fat and reduced testosterone proved more significant than the effect of age. Once researchers accounted for how fat was distributed across the body, the link between years lived and decreasing hormone levels was relatively small.
The concept that body fat influences testosterone is supported by earlier scientific literature. A 2007 study of more than 1,600 men demonstrated that a four to five point increase in body mass index was associated with a hormone reduction equivalent to roughly ten additional years of aging.
Similarly, a 2013 study that tracked more than 1,300 men over a five year period concluded that declining testosterone could not be blamed solely on getting older. That investigation found that lifestyle factors such as smoking, alongside health conditions including obesity and depression, played key roles in lower hormone levels.
Flaws in standard diagnostic tools
The researchers emphasized that standard tools commonly used to assess body weight and health risks, such as body mass index (BMI) and waist circumference, are insufficient for identifying hidden visceral fat. BMI is calculated by dividing body weight by height squared, but it fails to distinguish between muscle tissue, surface fat, and fat wrapped around internal organs.
Because of these limitations, two men with the exact same BMI can possess dramatically different amounts of deep abdominal fat. A young man who appears lean on the outside may carry dangerous levels of visceral fat around his internal organs, whereas an older man with higher muscle mass might retain very low levels of visceral fat.
Biological mechanisms and clinical recommendations
Scientists are still investigating the precise biological pathways through which visceral fat interferes with testosterone production. One leading explanation is that deep abdominal fat promotes insulin resistance, which can impair testicular processes involved in manufacturing testosterone.
Visceral tissue may also trigger systemic inflammation, alter broader hormonal signaling throughout the body, and encourage the activity of aromatase enzymes that convert testosterone into estradiol, a form of estrogen.
Study authors Karl Friedl and Adam Potter stated that evaluating where fat is concentrated provides crucial diagnostic insights that body weight alone cannot offer. They suggested that clinicians should evaluate metabolic factors and fat distribution before initiating testosterone replacement treatments.
Friedl and Potter noted that targeted reduction of visceral fat could offer a meaningful pathway for addressing testosterone deficiency. However, they added that further clinical studies are necessary to determine how much reducing deep abdominal tissue directly restores circulating hormone levels.
